عنوان

Continuous Ambulatory Peritoneal Dialysis in the USA :

(Number (ISBN

9400909314

(Number (ISBN

9789400909311

Number

b592511

Title Proper

Continuous Ambulatory Peritoneal Dialysis in the USA :

General Material Designation

[Book]

Other Title Information

Final Report of the National CAPD Registry 1981-1988

First Statement of Responsibility

edited by Anne S. Lindblad, Joel W. Novak, Karl D. Nolph.

Place of Publication, Distribution, etc.

Dordrecht

Name of Publisher, Distributor, etc.

Springer Netherlands

Date of Publication, Distribution, etc.

1989

Specific Material Designation and Extent of Item

(272 pages)

Series Title

Developments in nephrology, 23.

Text of Note

Section 1 Introduction --; Section 2 Registry Patient Population --; Section 3 Patient Characteristics --; Section 4 Complications of Treatment --; Section 5 Termination of Continuous Peritoneal Dialysis --; Section 6 Special Reports --; 1988 --; Section 7 Special Reports --; 1987 --; Section 8 Special Reports --; 1986 --; Section 9 Special Report --; 1985 --; Section 10 Special Report --; 1984 --; Appendices --; I. Executive Advisory Committee of the National CAPD Registry of the National Institutes of Health --; II. Participating Centers of the National CAPD Registry of the National Institutes of Health --; III. Bibliography of the National CAPD Registry of the National Institutes of Health --; Table of Exhibits --; Section 2 Registry Patient Population --; Exhibit 2-1 Number of Patients Registered by Class and Type of Dialysis --; 2-2 Number of Patients Registered by Class and Year of Registration --; 2-3 Number of Patients with Follow-up by Class and Type of Dialysis --; 2-4 Last Contact and Status According to Activity Classification of Center for Patients Last Reported to be on CAPD/CCPD --; 2-5 Currency of The National CAPD Registry Database by Class of Patient --; 2-6 Number of Patients Receiving CAPD at Year End --; 2-7 Census and Flow of The National CAPD Registry by Year --; Section 3 Patient Characteristics --; Exhibit 3-1 Percent of Patients with Selected Characteristics by Type of Therapy --; 3-2 CAPD --; Age Distribution by Sex --; 3-3 CCPD --; Age Distribution by Sex --; 3-4 CAPD --; Age Distribution by Race --; 3-5 CCPD --; Age Distribution by Race --; 3-6 CAPD --; Distribution of Patients by Primary Renal Disease Type According to Year of Registration --; Section 4 Complications --; Exhibit 4-1 CAPD --; Occurrence of Selected Complications by Class of Patients --; 4-2 CAPD --; Cumulative Probability of Experiencing First Episode of Peritonitis (Class 1 Patients Only) --; 4-3 CAPD --; Complication Rates by Year of Registration --; 4-4 CAPD --; Cumulative Probabilities and 95% Confidence Intervals (C.I.) of Experiencing Selected Events for the First Time by Year Registered (Class 1 Patients Only) --; 4-5 CAPD --; Cumulative Probability of Experiencing First Exit Site/Tunnel Infection (Class 1 Patients Only) --; 4-6 CAPD --; Cumulative Probability of First Catheter --; Replacement (Class 1 Patients Only) --; 4-7 CAPD --; Cumulative Probability of First Complication (Class 1 Patients Only) --; 4-8 CCPD --; Occurrence of Selected Complications by --; Class of Patient --; 4-9 CCPD --; Cumulative Probabilities and 95% Confidence Intervals (C.I.) of Experiencing Selected Events for the First Time by Number of Months on CCPD (Class 1 Patients Only) --; Section 5 Termination of Continuous Peritoneal Dialysis --; Exhibit 5-1 CAPD --; Cumulative Probability of Transfer (Class 1 Patients Only) --; 5-2 CAPD --; Cumulative Probability of Receiving a Kidney Transplant (Class 1 Patients Only) --; 5-3 CAPD --; Cumulative Probability of Death (Class 1 Patients Only) --; 5-4 CAPD --; Cumulative Probability of Discontinuing CAPD Therapy for any Reason (Class 1 Patients Only) --; 5-5 CCPD --; Cumulative Probability of Transfer (Class 1 Patients Only) --; 5-6 CCPD --; Cumulative Probability of Receiving a Kidney Transplant (Class 1 Patients Only) --; 5-7 CAPD --; Cumulative Probability of Death (Class 1 Patients Only) --; 5-8 CCPD --; Cumulative Probability of Discontinuing CCPD Therapy for Any Reason (Class 1 Patients Only) --; 5-9 CAPD or CCPD --; Cumulative Probability of Transplantation: Pediatrics vs. 'Standard' vs. 'Other' --; 5-10 CAPD or CCPD --; Cumulative Probability of --; Death: Pediatrics vs. 'Standard' vs. 'Other' --; 5-11 CAPD or CCPD --; Cumulative Probability of 'Technique Failure': Pediatrics vs. 'Standard' vs. 'Other' --; 5-12 Follow-up of Transfers to Hemodialysis Summary --; 5-13 Primary Reason for Leaving CAPD in Patients who Transferred from CAPD to Hemodialysis and Subsequently Returned to CAPD --; 5-14 Follow-up of Kidney Transplant Summary --; 5-15 Death Summary.

Text of Note

The Final Report of the USA CAPO Registry summarizes eight years of observation and analysis that reflects the experiences of 485 clinical centers and over 25,000 CAPO patients. As such, it offers a wealth of information, available here for the first time to interested parties around the world. Because the National Institutes of Health was quick to see the potential of CAPO as a promising therapy for patients with end stage renal disease, the Registry project was begun soon after its introduction into clinical practice in the USA. Accordingly, the Registry offered the nephrology community in the United States a special opportunity to study this emerging new therapy in some detail, an opportunity not previously available for any other form of dialysis. As will be seen in this report, the result of this early and intensive research effort has been the development of a vast amount of clinically important information regarding the utilization, safety, and efficacy of this important dialytic therapy.

Epidemiology.

Medicine.

Nephrology.

Class number

Book number

edited by Anne S. Lindblad, Joel W. Novak, Karl D. Nolph.

Anne S Lindblad

Joel W Novak

Karl D Nolph

Electronic name

[Book]

Y